Istituto Oncologico Veneto IRCCS
65
18
27
23
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
6.2%
4 terminated/withdrawn out of 65 trials
85.2%
-1.3% vs industry average
5%
3 trials in Phase 3/4
0%
0 of 23 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (65)
Negative Hormone Receptor and APOcrine Lobular Invasive Breast Cancer
Role: lead
Regorafenib for Recurrent Meningioma (MIRAGE Trial)
Role: lead
Assessing Financial Toxicity Using the PROFFIT Questionnaire in Patients Treated With Mini-invasive Approach for Urological Malignancies.
Role: lead
Incidence of Invasive Fungal Infections Among Patients With Acute Lymphoblastic Leukemia Ph-negative
Role: collaborator
Using Virtual Reality During PICC and PICC-PORT Placement in Cancer Patients
Role: lead
First-line Combination of Capecitabine and Oxaliplatin Plus Bevacizumab in Elderly Patients With Metastatic Colorectal Cancer
Role: lead
The GOLD Study: G8 in OLDer Patients
Role: lead
Cabozantinib in the Elderly With Metastatic Renal Cell Carcinoma
Role: lead
Electrochemotherapy (ECT) in Patients With Primary Visceral Tumors and/or Secondary Visceral Localizations, of Any Histotype
Role: lead
Pure Florid and Pleomorphic Lobular Carcinoma in Situ of the Breast: Towards an Increasingly Uniform Management
Role: lead
Lung Cancer Prevention Screening Programme in Italy
Role: collaborator
ImmunoNutrition and Colorectal Adenocarcinoma Surgery - INCAS Study
Role: lead
Scarless Advanced Breast Extended Oncoplasty: The ScarABEO Study
Role: lead
Immunological Phenotype of Desmoid-fibromatosis-affected Patients.
Role: collaborator
IntraOperative UltraSound Guided vs Wire Guided vs Magnetic Seed Guided Breast-Conserving Surgery for Non-palpable Tumors
Role: lead
LIver TrAnspLantation for Non-resectable Peri-HIlar cholangioCArcinoma (LITALHICA)
Role: collaborator
Next Generation Sequencing Method for the Detection of EGFR Gene Mutations in the Plasma of Patients With Lung Cancer
Role: lead
Diagnostic HER2DX-guided Treatment for Patients wIth Early-stage HER2-positive Breast Cancer
Role: collaborator
A Study to Evaluate Efficacy and Safety of Hydeal Cyst® Intravesical Instillations in Patients Treated With Intravesical Chemotherapy or Immunotherapy in Non-muscle Invasive Bladder Cancer
Role: lead
An Integrated Radio-immunological Approach
Role: lead